NIH provides funding for rare disease studies

The National Institutes of Health (NIH) has recently awarded $29 million toward the advancement of clinical research and investigation of treatments for rare diseases. This is part of a collaborative effort to expand the Rare Diseases Clinical Research Network...

Industry responds to FDA’s informed consent draft guidance

In response to FDA’s recent draft guidance on informed consent, industry affiliates such as the Association of Clinical Research Organizations (ACRO) and the Dana Farber Cancer Institute have provided detailed feedback in anticipation of the final guidance....

Drug companies seek more clinical trial volunteers

Among the many obstacles drug companies face in bringing a product to market, recruiting clinical trial volunteers has become increasingly difficult, according to  a recent article on www.washingtonpost.com by Lenny Bernstein. Bernstein states that more than 10% of...